ID

13081

Description

Flavopiridol in Treating Patients With Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00003256

Link

https://clinicaltrials.gov/show/NCT00003256

Keywords

  1. 1/15/16 1/15/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

January 15, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT00003256

Eligibility Prostate Cancer NCT00003256

Criteria
Description

Criteria

performance status: ecog 0-2
Description

ecog

Data type

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy: at least 3 months
Description

life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
wbc at least 3,000/mm3
Description

leukocytes

Data type

boolean

Alias
UMLS CUI [1]
C0023508
absolute neutrophil count at least 1,200/mm3
Description

absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelet count at least 100,000/mm3
Description

platelet count

Data type

boolean

Alias
UMLS CUI [1]
C0005821
hemoglobin at least 8 g/dl
Description

hemoglobin

Data type

boolean

Alias
UMLS CUI [1]
C0019046
bilirubin no greater than 1.5 mg/dl
Description

bilirubin

Data type

boolean

Alias
UMLS CUI [1]
C1278039
sgot no greater than 2.5 times normal
Description

sgot

Data type

boolean

Alias
UMLS CUI [1]
C0201899
creatinine no greater than 1.5 mg/dl
Description

creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0201976
prostate-specific antigen at least 10 ng/ml (if bone only disease)
Description

prostate-specific antigen

Data type

boolean

Alias
UMLS CUI [1]
C0138741
no prior or concurrent maligancies within 5 years, except nonmelanoma skin cancer
Description

prior malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
no serious medical illness
Description

serious medical illness

Data type

boolean

Alias
UMLS CUI [1]
C0009488
no cord compression symptoms
Description

cord compression symptoms

Data type

boolean

Alias
UMLS CUI [1]
C0037926
no prior chemotherapy
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
no prior suramin therapy
Description

suramin

Data type

boolean

Alias
UMLS CUI [1]
C0813205
prior or concurrent use of luteinizing hormone-releasing hormone allowed (no other concurrent hormonal therapy)
Description

LHRH therapy

Data type

boolean

Alias
UMLS CUI [1]
C0023610
no prior anti-androgen therapy within 4 weeks of study
Description

anti-androgen

Data type

boolean

Alias
UMLS CUI [1]
C0279492
at least 4 weeks since prior radiotherapy
Description

radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1522449
no prior strontium therapy
Description

strontium

Data type

boolean

Alias
UMLS CUI [1]
C0038467

Similar models

Eligibility Prostate Cancer NCT00003256

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
ecog
Item
performance status: ecog 0-2
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy: at least 3 months
boolean
C0023671 (UMLS CUI [1])
leukocytes
Item
wbc at least 3,000/mm3
boolean
C0023508 (UMLS CUI [1])
absolute neutrophil count
Item
absolute neutrophil count at least 1,200/mm3
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count at least 100,000/mm3
boolean
C0005821 (UMLS CUI [1])
hemoglobin
Item
hemoglobin at least 8 g/dl
boolean
C0019046 (UMLS CUI [1])
bilirubin
Item
bilirubin no greater than 1.5 mg/dl
boolean
C1278039 (UMLS CUI [1])
sgot
Item
sgot no greater than 2.5 times normal
boolean
C0201899 (UMLS CUI [1])
creatinine
Item
creatinine no greater than 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
prostate-specific antigen
Item
prostate-specific antigen at least 10 ng/ml (if bone only disease)
boolean
C0138741 (UMLS CUI [1])
prior malignancy
Item
no prior or concurrent maligancies within 5 years, except nonmelanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
serious medical illness
Item
no serious medical illness
boolean
C0009488 (UMLS CUI [1])
cord compression symptoms
Item
no cord compression symptoms
boolean
C0037926 (UMLS CUI [1])
chemotherapy
Item
no prior chemotherapy
boolean
C0392920 (UMLS CUI [1])
suramin
Item
no prior suramin therapy
boolean
C0813205 (UMLS CUI [1])
LHRH therapy
Item
prior or concurrent use of luteinizing hormone-releasing hormone allowed (no other concurrent hormonal therapy)
boolean
C0023610 (UMLS CUI [1])
anti-androgen
Item
no prior anti-androgen therapy within 4 weeks of study
boolean
C0279492 (UMLS CUI [1])
radiotherapy
Item
at least 4 weeks since prior radiotherapy
boolean
C1522449 (UMLS CUI [1])
strontium
Item
no prior strontium therapy
boolean
C0038467 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial